These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3278606)

  • 21. Impaired homeostatic mechanism of potassium handling after acute oral potassium load in diabetes mellitus.
    Kim HJ; Ahn YH; Park CH; Kang CM; Park HC; Bae HY; Choi SD
    J Korean Med Sci; 1993 Feb; 8(1):10-6. PubMed ID: 8343217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of acute hyperglycaemia on plasma potassium and aldosterone levels in type 2 (non-insulin-dependent) diabetes.
    Rosenstock J; Loizou SA; Brajkovich IE; Mashiter K; Joplin GF
    Diabetologia; 1982 Mar; 22(3):184-7. PubMed ID: 7042430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
    Weir MR; Bakris GL; Gross C; Mayo MR; Garza D; Stasiv Y; Yuan J; Berman L; Williams GH
    Kidney Int; 2016 Sep; 90(3):696-704. PubMed ID: 27350174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose-induced hyperkalemia in diabetic subjects.
    Nicolis GL; Kahn T; Sanchez A; Gabrilove JL
    Arch Intern Med; 1981 Jan; 141(1):49-53. PubMed ID: 7447584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potassium homeostasis in chronic diabetes mellitus.
    Perez GO; Lespier L; Knowles R; Oster JR; Vaamonde CA
    Arch Intern Med; 1977 Aug; 137(8):1018-22. PubMed ID: 327962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hyporeninemic hypoaldosteronism and the differential diagnosis of hyperkalemia].
    Weidmann P
    Schweiz Med Wochenschr; 1982 Dec; 112(49):1764-74. PubMed ID: 6758113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transient hypoaldosteronism after renal allotransplantation.
    Roll D; Licht A; Rösler A; Durst AL; Kleeman CR; Czaczkes JW
    Isr J Med Sci; 1979 Jan; 15(1):29-34. PubMed ID: 370059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoaldosteronemic hyporeninemic hyperkalemia after renal transplantation.
    Jones JW; Gruessner RW; Gores PF; Matas AJ
    Transplantation; 1993 Oct; 56(4):1013-5. PubMed ID: 8212180
    [No Abstract]   [Full Text] [Related]  

  • 29. Inadequate aldosterone response to hyperkalemia during angiotensin converting enzyme inhibition in chronic renal failure.
    Zanella MT; Mattei E; Draibe SA; Kater CE; Ajzen H
    Clin Pharmacol Ther; 1985 Dec; 38(6):613-7. PubMed ID: 2998675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperkalemia in diabetes mellitus.
    Uribarri J; Oh MS; Carroll HJ
    J Diabet Complications; 1990; 4(1):3-7. PubMed ID: 2141843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of plasma renin activity in a boy with chronic hyperkalemia.
    Sauder SE; Kelch RP; Grekin RJ; Kelsch RC
    Am J Dis Child; 1987 Aug; 141(8):922-7. PubMed ID: 3307388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulations of plasma aldosterone in young hyperkalemic patients with stable chronic renal failure.
    Radó JP; Boer P
    Endokrinologie; 1979 Apr; 73(2):173-85. PubMed ID: 467373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyponatremia and hyperkalemia in relation to hyperglycemia in insulin-treated diabetic out-patients.
    McNair P; Madsbad S; Christiansen C; Christensen MS; Transbøl I
    Clin Chim Acta; 1982 Apr; 120(2):243-50. PubMed ID: 7039873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potassium homeostasis in chronic experimental diabetes mellitus in rats.
    Hayashi M; Senba S; Saito I; Kitajima W; Saruta T
    Acta Endocrinol (Copenh); 1984 Feb; 105(2):239-44. PubMed ID: 6364673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary prostaglandins (PGE2 and PGI2) in hyporeninaemic hypoaldosteronism in diabetic patients with chronic renal failure.
    Gómez-Martino JR; Miralles JM; De Leon B; Hernandez MT; Tabernero JM
    Nephrol Dial Transplant; 1994; 9(3):251-6. PubMed ID: 8052430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney.
    van den Heuvel M; Batenburg WW; Jainandunsing S; Garrelds IM; van Gool JM; Feelders RA; van den Meiracker AH; Danser AH
    J Hypertens; 2011 Nov; 29(11):2147-55. PubMed ID: 21941204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renin-aldosterone responsiveness in uncomplicated juvenile-type diabetes mellitus.
    Moss S; Oster JR; Perez GO; Katz FH; Vaamonde CA
    Horm Res; 1978; 9(3):130-6. PubMed ID: 640577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potassium-lowering effect of albuterol for hyperkalemia in renal failure.
    Montoliu J; Lens XM; Revert L
    Arch Intern Med; 1987 Apr; 147(4):713-7. PubMed ID: 3827459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperkalemia due to hyporeninemic hypoaldosteronism with liver cirrhosis and hypertension.
    Kee CS; Choi JW; Chang DK; Ahn YH; Kim HJ
    J Korean Med Sci; 1993 Dec; 8(6):464-70. PubMed ID: 8179835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Risk for hyperkalemia during long-term treatment with angiotensin-converting enzyme inhibitors in insulin-dependent type 2 diabetics in relation to the glomerular filtration rate].
    Raml A; Schmekal B; Grafinger P; Biesenbach G
    Dtsch Med Wochenschr; 2001 Nov; 126(47):1327-30. PubMed ID: 11719857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.